These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35082187)

  • 1. Clinical Effect of Pulmonary Artery Diameter/Ascending Aorta Diameter Ratio on Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy.
    Shibata N; Hiraiwa H; Kazama S; Kimura Y; Araki T; Mizutani T; Oishi H; Kuwayama T; Kondo T; Morimoto R; Okumura T; Murohara T
    Circ J; 2022 Jun; 86(7):1102-1112. PubMed ID: 35082187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of pulmonary artery diameter to ascending aortic diameter and severity of heart failure.
    Chimura M; Ohtani T; Tsukamoto Y; Kioka H; Katsimichas T; Onishi T; Nakamoto K; Konishi S; Sengoku K; Miyawaki H; Hikoso S; Yamaguchi O; Sakata Y
    J Heart Lung Transplant; 2018 Nov; 37(11):1341-1350. PubMed ID: 30174167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
    Kimura Y; Okumura T; Morimoto R; Kazama S; Shibata N; Oishi H; Araki T; Mizutani T; Kuwayama T; Hiraiwa H; Kondo T; Murohara T
    ESC Heart Fail; 2021 Apr; 8(2):1359-1368. PubMed ID: 33471966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Blood Pressure and Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy with Spontaneous Mechanical Alternans.
    Watanabe M; Kashimura T; Ishizuka M; Kase M; Sakai R; Fujiki S; Takayama T; Ishihara S; Ozaki K; Inomata T
    Intern Med; 2023 Jun; 62(12):1707-1713. PubMed ID: 36351583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
    Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
    Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Matsumura Y; Hoshikawa-Nagai E; Kubo T; Yamasaki N; Kitaoka H; Takata J; Doi Y; Sugiura T
    Cardiovasc Ultrasound; 2015 Mar; 13():14. PubMed ID: 25880063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
    ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Amorim S; Campelo M; Martins E; Moura B; Sousa A; Pinho T; Silva-Cardoso J; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):253-60. PubMed ID: 27118094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Artery Diameter (PAD) and the Pulmonary Artery to Aorta Ratio (PAD/AAD) as Assessed by Non-contrast Cardiac CT: The Association with Left Ventricular (LV) Remodeling and the LV Function.
    Nguyen-Thu H; Ohyama Y; Taketomi-Takahashi A; Nguyen-Cong T; Sumiyoshi H; Nakamura T; Kurabayashi M; Tsushima Y
    Intern Med; 2022 Jun; 61(12):1809-1815. PubMed ID: 34776495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
    Kanamori H; Yoshida A; Naruse G; Endo S; Minatoguchi S; Watanabe T; Kawaguchi T; Tanaka T; Yamada Y; Takasugi N; Ishihara T; Mikami A; Miyazaki N; Nishigaki K; Minatoguchi S; Miyazaki T; Okura H
    J Am Coll Cardiol; 2022 Mar; 79(8):789-801. PubMed ID: 35210034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.
    Díez-López C; Salazar-Mendiguchía J; García-Romero E; Fuentes L; Lupón J; Bayés-Genis A; Manito N; de Antonio M; Moliner P; Zamora E; Catalá-Ruiz P; Caínzos-Achirica M; Comín-Colet J; González-Costello J
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricle reverse remodeling in chronic aortic regurgitation patients with dilated ventricle after aortic valve replacement.
    Zhang MK; Li LN; Xue H; Tang XJ; Sun H; Wu QY
    J Cardiothorac Surg; 2022 Jan; 17(1):8. PubMed ID: 35034651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial conduit strain derived from cardiac magnetic resonance is an independent predictor of left ventricular reverse remodeling in patients with nonischemic cardiomyopathy.
    Chen K; Chang L; Huang R; Wang Z; Mu D; Wang L
    BMC Med Imaging; 2024 Jan; 24(1):2. PubMed ID: 38166678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.
    Karatolios K; Chatzis G; Holzendorf V; Störk S; Richter A; Binas D; Schieffer B; Pankuweit S
    Dis Markers; 2018; 2018():2958219. PubMed ID: 30018673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.